The Dose & Lose Editorial Team is responsible for the guides on this site, published by Petros IT Solutions SRL, the publisher of Dose & Lose. The guides are researched from primary sources, such as prescribing information, regulator guidance and peer-reviewed clinical trials, and each one passes a check of its figures, arithmetic and sources before publication. Illustrative figures are labelled as illustrative in the text that introduces them.
No medical, pharmacy or dietetic qualification is claimed. These guides explain how GLP-1 medications and tracking work; they are not personal medical advice, and they never recommend a dose. Where a question needs a professional, the guide says so. See the editorial policy for how this content is produced, sourced and corrected, and send corrections to office@doseandlose.com.
Mounjaro and Zepbound side effects from both US labels: nausea, diarrhea and more as percentages at 5, 10 and 15 mg, plus the signs that need a doctor.
GLP-1 constipation: label rates for Ozempic, Wegovy, Mounjaro and Zepbound against placebo, why it happens, warning signs and what to ask a prescriber.
Mounjaro and Zepbound both contain tirzepatide. See how the US labels differ on use, dose steps and side effects, and why the EU and UK have no Zepbound.
Does Ozempic need to be refrigerated? Yes before first use. See each label's room-temperature days for Ozempic, Wegovy, Mounjaro and Zepbound in one table.
GLP-1 side effects by week: label dose schedules beside nausea, vomiting and diarrhea rates for the doses tested, plus warning signs that need a doctor.
Does Zepbound make you tired? See the fatigue figures on the Zepbound, Wegovy, Mounjaro and Ozempic labels, why it may happen and which signs need a doctor.